Aptar Pharma and Macquarie University partner on drug delivery project
Aptar Pharma is collaborating with Macquarie University in a partnership that will see the drug delivery specialist and Australian institution…
25 Sep 2026
FDA commissioner nominee affirms MMR vaccine safety despite Trump’s claims
Dr Heidi Overton, Donald Trump’s nominee to lead the US Food and Drug Administration (FDA), has affirmed the safety and effectiveness of the measles, mumps and rubella (MMR) vaccine, contrasting…
25 Sep 2026
Roche and Earendil forge $1.5bn bispecific discovery deal
Roche-owned Genentech has penned a blockbuster deal with Earendil Labs to discover and develop bispecific antibodies for oncology. In exchange for $55m upfront and up to $1.445bn in development, regulatory…
25 Sep 2026
Amberstone and Henlius agree to develop solid-tumour T-cell engagers
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours. The preclinical T-cell engagers will be developed…
25 Sep 2026
FDA approves Lilly’s Onswik for type 2 diabetes in adults
The US Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin injection for adults with type 2 diabetes (T2D). This…
24 Sep 2026
Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare
Eli Lilly has partnered with China-based InnoCare Pharma in a five-drug strong research and license pact. As per the deal, Lilly will pay up to $100m upfront, with a further…
24 Sep 2026
Australia starts investigation into OpenAI Medicare breach
The Australian government has initiated a review into a hacking incident in which tech giant OpenAI’s artificial intelligence (AI) model secured unintended access to private health files, marking one of…